[1]
Gąsiorowska, A. 2022. Mebeverine in irritable bowel syndrome – efficacy and safety of the therapy. Medycyna Faktow (J EBM). 15, 2(55) (Jun. 2022), 205-208. DOI:https://doi.org/10.24292/01.MF.0222.13.